Adults taking tirzepatide lose an average of 15 kilograms over six months while experiencing a 35% reduction in fat mass and preserving skeletal muscle. A study published in the Journal of Diabetes and Its Complications tracked 122 overweight and obese patients in Palermo, Italy, to measure real-world changes in body composition and metabolic health. Patient … Read more
Odonkor, M.R. Dodurgali, F.R. Cox, I.J. Klimov, and A. Abd-Elsayed in the journal Nutrients, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may alleviate chronic pain by interacting with the gut microbiome and the gut-brain axis. The study examines how microbial metabolites, spinal microglia, and dietary signaling intersect with pain sensitization pathways. Gut Microbiota and GLP-1 Signaling … Read more
According to a study published in the Journal of Asthma and Allergy by researchers C.-T. Hung, C.-Y. An, C.-W. Suk, T.-W. Lee, and S.-H. Hung, adult patients with asthma and type 2 diabetes who use tirzepatide experience a similar risk of asthma exacerbations over a 12-month period compared to those using semaglutide. The retrospective cohort … Read more
Millions of patients taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) for type 2 diabetes and obesity face renewed clarity regarding psychiatric safety, according to a systematic review published in the journal Cureus by Quadir et al. Researchers evaluating 11 primary studies representing over 4.9 million patients found no consistent class-wide increase in neuropsychiatric risks such as … Read more
According to a randomized clinical trial published in the journal Cell Metabolism, a very-low-carbohydrate ketogenic diet reduces liver fat and improves insulin sensitivity significantly more than Mediterranean or plant-forward diets when participants achieve a comparable 10% weight loss. Researchers found that dietary macronutrient composition independently alters metabolic responses, yielding a 67% reduction in hepatic triglycerides … Read more
FOXA2 serves as a master transcription factor that coordinates pancreatic development, maintains islet cell identity, and regulates systemic glucose homeostasis, according to a review published in the journal Genes & Diseases (DOI: 10.1016/j.gendis.2025.101972). By orchestrating gene networks from early organogenesis into adulthood, FOXA2 ensures the functional integrity of insulin-producing β-cells and glucagon-secreting α-cells, providing a … Read more
Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), triggers rapid but largely reversible shifts in the gut microbiome of obese mice, according to a study published in the journal Microbiology Spectrum. Researchers found that while the drug alters bacterial community structure during active treatment, these changes largely normalize within seven days of discontinuing the medication. … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
New research suggests that the cardiovascular health benefits of semaglutide may be more closely tied to the drug’s dosage than to the amount of weight a patient loses. A retrospective study published in npj Cardiovascular Health found that patients reaching higher maximum doses of semaglutide—1.7 mg or greater—experienced significantly lower risks of heart failure, cerebrovascular … Read more
A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more